Several of the nation’s largest pharmaceutical companies said they plan to tighten screening of physicians who promote their drugs after ProPublica reported last month that more than 250 of them had been sanctioned for misconduct. Eli Lilly and Co. said that next year, for the first time, it would hire an [...]

Ten companies were recognized today at this year’s World Business and Development Awards (WBDA) for their efforts in improving the lives of some of the world’s most disadvantaged communities. [...]

The drug maker Eli Lilly & Co. plans to create a public database listing the names of physicians it pays for speaking engagements and consulting services, the company will announce Wednesday. The new policy puts Lilly at the forefront of the drug industry as the firm seeks to cement its reputation as a leader [...]

Increased attention on product human risk and smaller media coverage of drug donations have challenged Pharmaceuticals’ ethical reputation last year, states a report published today by Geneva-based research firm Covalence – Covalence Pharmaceutical Industry Report 2008. The pharmaceutical industry dropped from the first to the third rank of Covalence all-time EthicalQuote ranking across 10 industries. [...]

Amid increasing governmental and professional concerns about payments to physicians by pharmaceutical companies, major drug manufacturer Eli Lilly announced its support for legislation to increase public trust in the healthcare industry. Independent studies have shown a significant financial link between the drug industry and practicing physicians. Ninety-four percent of doctors reported that they have some [...]

Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical trials, drug side-effects and transparency. In terms of ethical reputation, innovation seems to bring more [...]

A decade ago the Minnesota Board of Medical Practice accused Dr. Faruk Abuzzahab of a “reckless, if not willful, disregard” for the welfare of 46 patients, 5 of whom died in his care or shortly afterward. The board suspended his license for seven months and restricted it for two years after that. But Dr. Abuzzahab, [...]

In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and charts by collecting reports – both positive and negative recent news – from the Internet [...]